In 2023, a Dutch actuary working for a Singapore-based insurer faced a familiar problem: the city-state had no credible morbidity data for disability income insurance. Rather than wait years for local experience to accumulate, he imported the German DAV 1997/2008 tables wholesale. The product launched with a 15% margin loading, and regulators demanded a five-year monitoring plan. Two years in, claims are running 8% above expected, and the company has already filed for a rate increase. This is the story of a pricing decision that should not have worked—and might still fail.

The Product Transfer That Shouldn't Work

Singapore's disability income market is small, with only a handful of carriers offering individual policies. The Monetary Authority of Singapore (MAS) requires insurers to use credible local data, but for disability income, that data barely exists. The population of roughly 5.6 million generates too few claims to build robust incidence and recovery tables. Actuaries have two options: wait a decade or borrow from a larger market.

The German DAV 1997/2008 tables are among the most widely used private morbidity studies in Europe. They cover over 5 million lives, segmented by occupation class, age, gender, and elimination period. For a product manager in Singapore, they offered a ready-made foundation. But the populations differ in ways that matter. Singaporean life expectancy at birth is about 83 years, compared to 81 in Germany. Disability incidence rates for white-collar workers in Germany peak at ages 45–55; in Singapore's younger workforce, that peak shifts roughly three years earlier.

The Dutch actuary, whom we'll call the lead pricing actuary for this project, estimated that raw incidence rates could differ by 20% to 30% between the two populations. He presented the board with a range of possible outcomes, from 10% below to 40% above German experience. The board approved a 15% margin loading, effectively a surcharge on the net premium to absorb the gap. The regulator allowed the filing under a 2019 guideline that permits foreign data with explicit loading and a monitoring plan.

The product launched in early 2024. By mid-2026, the actual-to-expected claims ratio stood at 1.08—within the 110% trigger that would require a full review, but close enough to worry the pricing team. The margin loading had already been eroded by higher-than-expected musculoskeletal claims.

How German Morbidity Tables Are Built

The DAV 1997/2008 tables are the product of a decade-long collaboration between the German Actuarial Association (DAV) and a pool of private insurers. The underlying data comes from policies issued between 1985 and 2005, covering roughly 5 million life-years. The tables provide incidence rates for disability—defined as inability to perform one's job for a specified period—plus recovery and mortality rates for disabled lives.

Occupational class is the strongest predictor. White-collar workers in Germany show incidence rates roughly 60% lower than blue-collar workers in heavy industry. The tables break down into six occupation classes, each with its own age-gender grid. Elimination periods of 3, 6, 12, and 24 months are modeled separately, reflecting the higher probability of recovery for short claims.

Recovery rates are a critical but often overlooked component. For claims under 12 months, German recovery rates are high—around 70% within the first year for white-collar workers. For claims lasting more than two years, recovery drops sharply to under 10%. This bimodal pattern is typical of disability experience, but it varies by jurisdiction. In Singapore, the early claims data shows recovery rates roughly 10% faster than the German table predicted, possibly because of different return-to-work incentives.

The tables are recalibrated roughly every decade, but no Singapore-specific adjustment has ever been attempted. The 2023 version of the tables includes a mortality improvement assumption of 0.5% per year for disabled lives, based on German trends. Singapore's mortality improvement has been faster, around 0.8% per year for the general population, but data on disabled lives is too sparse to confirm.

The Three Big Mismatches in Transfer

The first mismatch is occupation mix. Singapore's economy relies heavily on manufacturing, logistics, and construction—sectors that employ a higher proportion of shift workers and manual laborers than Germany's service-dominated workforce. German tables for blue-collar workers may not capture the specific injury patterns of Singapore's manufacturing sector, where repetitive strain and back injuries are common. In the first two years, musculoskeletal claims were 15% above the German table prediction.

The second mismatch is the healthcare system. Singapore's healthcare system is a hybrid of public and private provision, with mandatory savings accounts (MediSave) and means-tested subsidies. Claim duration is influenced by how quickly a patient can access treatment and rehabilitation. Germany's statutory health insurance system has different waiting times and coverage limits. The actuary assumed that Singapore's faster access to specialist care would reduce claim durations, but the early data shows the opposite: average claim duration is slightly longer than the German table implies, especially for back injuries.

The third mismatch is mortality improvement. German tables assume disabled lives experience higher mortality than the general population, with an improvement rate of 0.5% per year. Singapore's general mortality is improving faster, but the gap between disabled and non-disabled mortality may be wider. If disabled lives in Singapore are living longer than the German table assumes, the insurer will pay claims for more years than priced. The actuary added a 5% buffer to the mortality assumption, but the true impact may be larger.

Lapse behavior is another unknown. German policyholders lapse disability income policies at an annual rate of 8% to 12%, depending on the policy year. Singapore's insurance market has higher persistency for life products, but disability income is newer. If lapses are lower than assumed, the insurer will retain more policies with older, sicker lives. The current block of business has seen lapses of only 6% in the first two years, which is good for revenue but bad for risk selection.

Pricing Mechanics Under the Hood

The net premium for a disability income policy is calculated as the present value of expected claims divided by the present value of premium payments. For a 35-year-old male white-collar worker with a 12-month elimination period and a benefit of SGD 3,000 per month to age 65, the German table yields an annual net premium of roughly SGD 540. The calculation uses a discount rate of 3.5%, which reflects German bond yields at the time the table was built.

Singapore's interest rate environment is different. The actuary used a discount rate of 5%, based on Singapore government bond yields and the insurer's investment strategy. A higher discount rate reduces the present value of future claims, lowering the net premium. But it also reduces the value of future premium income. The net effect was a 12% reduction in the net premium compared to using the German rate. Some actuaries argue this is aggressive, especially for a long-duration product where interest rate assumptions compound over decades.

The loaded premium includes expenses (acquisition, administration, and claims handling) plus the 15% margin. The expense load added roughly 25% to the net premium, and the margin added another 12% on top of that. The gross annual premium for the sample policy came to about SGD 780. The company also set aside an additional reserve equal to 10% of net premium, as required by the MAS for products using foreign morbidity tables.

Reinsurance played a role in limiting downside. The treaty covers individual claims above SGD 500,000, which is rare for disability income but possible for high-income professionals. The reinsurer reviewed the pricing and accepted the German table with a 10% loading on top of the direct writer's margin. This effectively capped the insurer's loss on any single claim at SGD 500,000, but the aggregate risk from many smaller claims remains on the direct writer's books.

Regulatory Pushback and Actuarial Workarounds

The Monetary Authority of Singapore did not approve the filing without conditions. The regulator required an experience monitoring plan that triggers a full review if cumulative claims exceed 110% of expected in any rolling 12-month period. The insurer must file quarterly reports comparing actual to expected claims by cause, age, and occupation class. If the trigger is breached, the company must submit a remediation plan within 90 days.

The company also holds an additional reserve equal to 10% of net premium, as noted. This reserve is released gradually as credible local experience accumulates—roughly 2% per year after the first five years. The Dutch actuary argued that the reserve was conservative, given the 15% margin in the premium, but the regulator insisted. As of mid-2026, the reserve had grown to about SGD 2 million, representing a drag on return on equity.

In 2025, rating agency Moody's published a report on basis risk in Asian insurance markets, citing this product as an example. The report noted that the 15% margin might be insufficient if the true incidence difference exceeds 20%, and recommended that investors demand explicit disclosure of foreign table usage. The insurer responded by publishing a white paper detailing the assumptions and monitoring results, but the market reaction was muted.

A peer review by the Singapore Actuarial Society found no material error in the pricing methodology, but flagged two concerns: the reliance on a single source table, and the lack of a Bayesian credibility adjustment. The society recommended blending the German table with a small amount of local data using a credibility factor, even if the local data is thin. The company has since commissioned a local experience study, with results expected in 2028.

What the First Two Years of Claims Reveal

The actual-to-expected claims ratio after 24 months is 1.08, meaning claims are 8% higher than the German table predicted. This is below the 110% trigger but above the pricing assumption of 1.00. The margin loading of 15% has absorbed the excess, but if the trend continues, the product will be unprofitable by year five.

Musculoskeletal claims are the main driver. Back injuries, herniated discs, and repetitive strain conditions make up 40% of total claims, compared to 35% in the German table. The incidence rate for these conditions is 15% higher than expected. The actuary hypothesizes that Singapore's manufacturing and logistics workers face different physical demands than German white-collar workers, but the data is too thin to confirm.

Mental health claims, by contrast, are 25% lower than the German table predicted. This could reflect underreporting due to social stigma, or it could indicate that Singapore's workplace culture discourages disability claims for stress and depression. The recovery rate for mental health claims is also faster—about 80% within 12 months, compared to 65% in the German experience. The net effect is that mental health claims are not yet a problem, but the actuary expects them to rise as awareness grows.

Recovery rates overall are 10% faster than the German table. For claims with a 12-month elimination period, the probability of recovery within 24 months is 55% in Singapore, versus 50% in the German data. This is partly offset by higher incidence, but it means that claim durations are shorter than assumed. The net impact on reserves is roughly neutral so far, but the company is watching the trend closely.

The company filed for a 5% rate increase on new business in 2026, citing the higher-than-expected claims. The regulator approved the increase, noting that existing policyholders are not affected. The new rate will apply to policies issued after January 2027. The actuary estimates that the increase will bring the expected loss ratio back to 85%, within the target range.

Lessons for Cross-Border Product Development

The first lesson is never to import morbidity tables without a local calibration study. Even a small sample of local data, combined with the source table using Bayesian credibility, can reduce basis risk. The Dutch actuary's team is now working on a credibility-weighted blend that gives the German table a weight of 0.7 and local data a weight of 0.3, which would have reduced the initial margin requirement.

The second lesson is to build automatic experience adjustment clauses into the product design. The current product has a guaranteed premium for the policy duration, which means the insurer cannot adjust rates for existing policyholders. Future products will include a provision for premium adjustment based on the block's experience, subject to regulatory approval. This is common in group disability but rare in individual lines.

The third lesson is to involve the reinsurer early. The reinsurer's review helped validate the pricing assumptions and provided a stop-loss for large claims. For smaller insurers, a quota share reinsurance treaty could spread the basis risk across a broader portfolio. The Singapore market is too small for a pure captive approach; diversification across jurisdictions is essential.

Finally, regulators should demand explicit basis risk disclosure. The MAS's monitoring plan is a good start, but investors and rating agencies need standardized metrics. The Dutch actuary now includes a "basis risk adjustment" in his pricing reports, expressed as a percentage of net premium. This allows the board to see the impact of using foreign tables on the bottom line. As cross-border product development grows—especially for disability and long-term care—these disclosures will become standard practice.

The product is not yet profitable, but it is not a failure either. The 8% excess claims are within the margin, and the rate increase should restore profitability for new business. The real test will come in years five to ten, when the block matures and the cumulative claims experience becomes more credible. For now, the Dutch actuary's gamble is still alive—but the next iteration will be built on local data, not imported tables.

This article is for informational purposes only and does not constitute professional actuarial or insurance advice. Readers should consult a qualified actuary or financial advisor for guidance specific to their circumstances.